Two-Component Cluster Analysis of a Large Serodiagnostic Database for Specificity of Increases of IgG Antibodies against Pertussis Toxin in Paired Serum Samples and of Absolute Values in Single Serum Samples

ABSTRACT Measuring IgG antibodies against pertussis toxin (IgG-Ptx) with an enzyme-linked immunosorbent assay (ELISA) can be used to diagnose pertussis infection; however, the cutoff points are not unanimously defined. To determine the diagnostic specificity of increases of IgG-Ptx in paired sera and of absolute values in single serum samples, we applied a two-component cluster analysis to serum samples of patients suspected for pertussis, whose sera had been submitted to a routine diagnostic laboratory between 2003 and 2009, and had been assayed with an in-house IgG-Ptx ELISA calibrated with the international FDA lot 3 IgG-Ptx reference serum. Children eligible for the acellular pertussis vaccination were excluded to avoid interference from a vaccine-induced IgG-Ptx rise. Binary distribution mixtures were fitted to the data. Receiver operating characteristic (ROC) curves were calculated for absolute values in single samples (n = 14,452) and increases in paired samples (n = 2,455). For both parameters, two subpopulations could be identified: a population with high reactivity (persons with pertussis infection) and a population with low reactivity (persons without pertussis infection). For absolute values in single samples, the area under the curve (AUC) of the ROC curve was 0.993 and the optimum cutoff (with the highest cumulative value of specificity plus sensitivity) was 67.7 IU/ml (95% confidence interval, 63.9 to 74.1; sensitivity, 96.4%; specificity, 95.7%). A previously determined diagnostic cutoff of 125 IU/ml was associated with a sensitivity of 88.1% and a specificity of 98.8%. For increases in paired sera, the AUC was 0.999 and the optimum cutoff was 3.1-fold (95% CI, 2.8 to 3.4; sensitivity, 99.6%; specificity, 99.2%). Given the methodology of this study, estimates of sensitivity probably are overrated (because pertussis patients without IgG-Ptx response are not detected), but estimates of specificities can be considered very accurate.

[1]  E. Sanders,et al.  Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children. , 2011, Vaccine.

[2]  F. Mooi,et al.  Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis , 2010, PloS one.

[3]  G. Berbers,et al.  What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[4]  J. Mertsola,et al.  Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  K. Krogfelt,et al.  Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine. , 2010, Journal of medical microbiology.

[6]  F. Mooi,et al.  Pertussis disease burden in the household: how to protect young infants. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  M. Corbel,et al.  Characterization of Reference Materials for Human Antiserum to Pertussis Antigens by an International Collaborative Study , 2008, Clinical and Vaccine Immunology.

[8]  A. Van Rie,et al.  Comparison of Serological and Real-Time PCR Assays To Diagnose Bordetella pertussis Infection in 2007 , 2008, Journal of Clinical Microbiology.

[9]  J. Mertsola,et al.  Immunity to pertussis 5 years after booster immunization during adolescence. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  N. Guiso,et al.  Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life. , 2007, Vaccine.

[11]  A. Chatterjee,et al.  A modified "cover your cough" campaign prevents exposures of employees to pertussis at a children's hospital. , 2005, American journal of infection control.

[12]  D. Bernstein,et al.  Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT). , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  M. Massari,et al.  Resurgence of Pertussis in Europe , 2005, The Pediatric infectious disease journal.

[14]  J. Schellekens,et al.  Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis , 2005, Epidemiology and Infection.

[15]  P. Horby,et al.  A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods , 2004, Epidemiology and Infection.

[16]  K. Edwards,et al.  Establishment of Diagnostic Cutoff Points for Levels of Serum Antibodies to Pertussis Toxin, Filamentous Hemagglutinin, and Fimbriae in Adolescents and Adults in the United States , 2004, Clinical Diagnostic Laboratory Immunology.

[17]  A. Nardone,et al.  The seroepidemiology of Bordetella pertussis infection in Western Europe , 2004, Epidemiology and Infection.

[18]  D. Greenberg,et al.  Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. , 2004, The Journal of infectious diseases.

[19]  J. Schellekens,et al.  European Sero-Epidemiology Network: standardisation of the assay results for pertussis. , 2003, Vaccine.

[20]  J. Schellekens,et al.  Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis , 2002, Epidemiology and Infection.

[21]  L. Irwig,et al.  Serological diagnosis of pertussis: evaluation of IgA against whole cell and specific Bordetella pertussis antigens as markers of recent infection , 2002, Epidemiology and Infection.

[22]  W. Yih,et al.  The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. , 2000, The Journal of infectious diseases.

[23]  J. Schellekens,et al.  Specificity and Sensitivity of High Levels of Immunoglobulin G Antibodies against Pertussis Toxin in a Single Serum Sample for Diagnosis of Infection with Bordetella pertussis , 2000, Journal of Clinical Microbiology.

[24]  H. Schmitt,et al.  Evaluation of a Single-Sample Serological Technique for Diagnosing Pertussis in Unvaccinated Children , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[25]  H. Hallander Microbiological and serological diagnosis of pertussis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  F. Simondon,et al.  Evaluation of an Immunoglobulin G Enzyme-Linked Immunosorbent Assay for Pertussis Toxin and Filamentous Hemagglutinin in Diagnosis of Pertussis in Senegal , 1998, Clinical Diagnostic Laboratory Immunology.

[27]  T. Kato,et al.  Simple, speedy, sensitive, and specific serodiagnosis of pertussis by using a particle agglutination test , 1997, Journal of clinical microbiology.

[28]  F. Mooi,et al.  A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. , 1996, The Journal of infectious diseases.

[29]  G. Siber,et al.  Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness. , 1994, The Journal of infectious diseases.

[30]  S. de Graaf,et al.  Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels. , 1985, Developments in biological standardization.

[31]  J. Nagel,et al.  Serum IgA antibody to Bordetella pertussis as an indicator of infection. , 1983, Journal of medical microbiology.